JAK2 is dispensable for maintenance of JAK2 mutant B-cell acute lymphoblastic leukemias [Research Papers]

Kim, S.-K., Knight, D. A., Jones, L. R., Vervoort, S., Ng, A. P., Seymour, J. F., Bradner, J. E., Waibel, M., Kats, L., Johnstone, R. W.
Cold Spring Harbor Laboratory Press
Published 2018